Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
18.72
+0.12 (0.65%)
At close: Apr 30, 2026, 4:00 PM EDT
18.90
+0.18 (0.96%)
After-hours: Apr 30, 2026, 7:59 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.97 billion as of April 30, 2026. Its market cap has increased by 55.32% in one year.
Market Cap
2.97B
Enterprise Value
2.05B
1-Year Change
55.32%
Ranking
Category
Stock Price
$18.72
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.97B, an increase of 57.40%. That is a compound annual growth rate of 5.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 2.97B | 22.61% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 3.53B |
| Edgewise Therapeutics | 3.28B |
| NewAmsterdam Pharma Company | 3.27B |
| Erasca | 3.18B |
| Structure Therapeutics | 3.18B |
| Arcus Biosciences | 3.06B |
| Beam Therapeutics | 3.05B |
| Alumis | 3.02B |